ROME, December 13. / TASS /. A detailed presentation of Russia’s COVID-19 vaccine Sputnik V took place at the international pandemic conference in Palermo on Monday. The conference was organized on the initiative of the University of Palermo with the support of the town hall. Many leading specialists involved in the study of the new coronavirus took part.
Senior researcher Darya Yegorova, from the Laboratory of Genetic Engineering of Pathogenic Microorganisms at the National Epidemiology and Microbiology Research Center of Gamaleya briefed the public on the vaccine testing phases and also reviewed the results of research on the vaccine efficacy, gathered in a number of countries, including Argentina and San Marino. Conference organizers said that one of the purposes of inviting a Russian specialist is to take an in-depth look at the Russian experience.
Russian Consul General in Palermo Sergey Patronov told TASS that the Russian specialist’s report attracted considerable attention.
âThe representatives of the professional community present were very interested in obtaining first-hand information about the efforts of Russian researchers and the results obtained. This is the first time that a Russian specialist has been invited to an event of such a level. Many noted the objective dearth of information about the Russian vaccine. In the meantime, better knowledge of its properties could help gain recognition in Europe, âPatronov said.
The Sputnik V vaccine, registered in Russia on August 11, 2020, was the world’s first officially recognized vaccine against the coronavirus. To date, the vaccine has been approved in 71 countries. Although the Russian vaccine has not yet been recognized by the European Union, a number of European governments have made the decision to let travelers vaccinated with Sputnik V visit their countries without further restrictions.